Wuhan Dgensee Medical Laboratory Co., Ltd. announced a private placement of common shares for gross proceeds of CNY 1,200,000 on January 26, 2022. The transaction will include participation from new investors Shenzhen YHLO Biotech Co., Ltd. for CNY 825,413, Shenzhen Puhui Zhonglian Industrial Investment Co., Ltd. for CNY 277,472, Yao Yiyu for CNY 97,115. The transaction has been approved at the 4th session, the 3rd directorate and the 4th session of the 3rd supervisory board of Shenzhen YHLO Biotech Co., Ltd. Post the closing, the registered capital of the company will increase from CNY 13,000,000 to CNY 14,200,000.
Shenzhen YHLO Biotech Co., Ltd.
Equities
688575
CNE100005204
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.03 CNY | +2.08% | +14.37% | +5.07% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.07% | 1.85B | |
+73.17% | 12.34B | |
-18.74% | 7.96B | |
+16.15% | 7.16B | |
+4.81% | 5.72B | |
+5.99% | 5.03B | |
+27.07% | 4.35B | |
-21.67% | 3.99B | |
-40.82% | 2.21B | |
+1.49% | 2.01B |
- Stock Market
- Equities
- 688575 Stock
- News Shenzhen YHLO Biotech Co., Ltd.
- Wuhan Dgensee Medical Laboratory Co., Ltd. announced that it expects to receive CNY 1.2 million in funding from Shenzhen YHLO Biotech Co., Ltd., Shenzhen Puhui Zhonglian Industrial Investment Co., Ltd. and another investor